Acquisition growth Crown Aesthetics is expanding its product portfolio through the acquisition of Eclipse Medical’s global aesthetics assets, presenting cross-sell and upsell opportunities across its existing skincare and device lines.

FDA cleared devices Recent launches of FDA-cleared microneedling devices like SkinPen Precision Elite create potential for partner sales, bundled solutions, and procurement conversations with clinics seeking compliant, high-efficacy tools.

UK and Ireland focus New leadership in the UK & Ireland for SkinPen and Biojuve indicates a channel-focused expansion; prioritize regional outbound outreach, distributor alignment, and localized marketing campaigns.

Customer experience Crown won a 2024 Excellence in Customer Service Award, signaling a strong service proposition to differentiate in efficacy-focused procurement discussions with medical practices and aesthetic clinics.

Digital and partnerships Active tech stack and strategic partnerships (GetHarley in the UK/Ireland) suggest opportunities to tailor digital health integrations, patient journey solutions, and co-marketing to drive device and regimen adoption.